[62] Because of the hepatic metabolism of repaglinide, the manufacturer recommends that a repaglinide-metformin combination tablet should be avoided in patients with hepatic impairment. On a ...
Expert Rev Endocrinol Metab. 2010;5(3):331-342. Metformin also forms the cornerstone of dual therapy and is used extensively in combination with several classes of OADs. The safety and efficacy of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results